- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有215家主力机构披露2025-06-30报告期持股数据，持仓量总计2.01亿股，占流通A股30.04%
- 波段诊断：
-
技术面诊股
诊断结果：5.6技术面打败了53%的股票
技术面评分前10的股票
近期的平均成本为15.94元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为15.94元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.94","date":1770624231,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2026.02.10","stock":"0.06","trade":null,"ind":"0.02"},{"date":"2026.02.09","stock":"0.95","trade":null,"ind":"2.17"},{"date":"2026.02.06","stock":"-1.19","trade":null,"ind":"-0.33"},{"date":"2026.02.05","stock":"0.19","trade":null,"ind":"-1.44"},{"date":"2026.02.04","stock":"0.31","trade":null,"ind":"2.40"},{"date":"2026.02.02","stock":"-0.76","trade":null,"ind":"-2.69"},{"date":"2026.01.30","stock":"-0.82","trade":null,"ind":"-0.66"},{"date":"2026.01.29","stock":"1.40","trade":null,"ind":"-0.30"},{"date":"2026.01.28","stock":"-2.42","trade":null,"ind":"0.09"},{"date":"2026.01.27","stock":"-2.13","trade":null,"ind":"0.09"},{"date":"2026.01.26","stock":"-0.30","trade":null,"ind":"-0.85"},{"date":"2026.01.23","stock":"2.68","trade":null,"ind":"0.79"},{"date":"2026.01.22","stock":"-0.74","trade":null,"ind":"0.50"},{"date":"2026.01.21","stock":"0.31","trade":null,"ind":"0.70"},{"date":"2026.01.20","stock":"-0.62","trade":null,"ind":"-0.97"},{"date":"2026.01.19","stock":"-0.98","trade":null,"ind":"0.09"},{"date":"2026.01.16","stock":"-1.26","trade":null,"ind":"-0.18"},{"date":"2026.01.15","stock":"-0.24","trade":null,"ind":"0.41"},{"date":"2026.01.14","stock":"1.59","trade":null,"ind":"0.56"},{"date":"2026.01.13","stock":"-1.56","trade":null,"ind":"-1.37"},{"date":"2026.01.12","stock":false,"trade":null,"ind":"1.75"}]
欧普康视,深证成指,医疗器械指数
压力支撑
该股压力位为15.92元，支撑位为15.82元。
[{"text":"\u538b\u529b\u4f4d","value":"15.92","date":1770652800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.82","date":1770652800,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.8资金面打败了32%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：02月10日 20:30
| 机构今日流向(万元) | -592.41 | 机构5日流向(万元) | -1373.44 |
| 机构10日流向(万元) | -8272.77 | 机构20日流向(万元) | -20509.11 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少2435.7万股，其中基金净减仓41家，主力净减仓8家，请投资者中长期谨慎为宜。
截止2025-06-30，共215家主力机构（基金211家，一般法人3家，券商1家），持仓量总计20080.94万股，占流通A股30.04%
其中，基金持仓与2024-12-31相比：
增仓：42家 ，增持 197.47万股
减仓：83家 ，减持 239.42万股
新出现在主力名单中：68家 ，持有641.85万股
从主力名单中消失：76家 ，原持有750.65万股
其中，基金持仓与2024-12-31相比：
增仓：42家 ，增持 197.47万股
减仓：83家 ，减持 239.42万股
新出现在主力名单中：68家 ，持有641.85万股
从主力名单中消失：76家 ，原持有750.65万股
消息面诊股
诊断结果：5.5消息面打败了42%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 欧普康视：2月9日获融资买入2444.76万元
2026-02-10 - 欧普康视：2月6日获融资买入1784.68万元
2026-02-09 - 欧普康视：公司的阿托品目前仍在三期临床试验阶段
2026-02-05 - 欧普康视：2月4日获融资买入2471.43万元
2026-02-05 - 欧普康视：公司将于2026年3月28日披露年报
2026-02-04 - 欧普康视（截止2026年1月30日）股东人数为62
2026-02-04 - 欧普康视：1月29日获融资买入1465.44万元
2026-01-30 - 欧普康视：公司不存在ST或退市风险的情形
2026-01-28 - 欧普康视：1月27日获融资买入2985.94万元
2026-01-28 - 欧普康视：截至2026年1月20日股东总人数为63
2026-01-27
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-05 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-18 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-12-09 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-12 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-09 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-27 |
| 利好 | 分红转增 | 10派0.56元(含税) | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-02 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-18 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-02 |
| 利好 | 分红转增 | 10派2.24元(含税) | 2025-03-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-21 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了3%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.02.10","price":"0.02","value":null},{"date":"2026.02.09","price":"2.17","value":null},{"date":"2026.02.06","price":"-0.33","value":null},{"date":"2026.02.05","price":"-1.44","value":null},{"date":"2026.02.04","price":"2.40","value":null},{"date":"2026.02.02","price":"-2.69","value":null},{"date":"2026.01.30","price":"-0.66","value":null},{"date":"2026.01.29","price":"-0.30","value":null},{"date":"2026.01.28","price":"0.09","value":null},{"date":"2026.01.27","price":"0.09","value":null},{"date":"2026.01.26","price":"-0.85","value":null},{"date":"2026.01.23","price":"0.79","value":null},{"date":"2026.01.22","price":"0.50","value":null},{"date":"2026.01.21","price":"0.70","value":null},{"date":"2026.01.20","price":"-0.97","value":null},{"date":"2026.01.19","price":"0.09","value":null},{"date":"2026.01.16","price":"-0.18","value":null},{"date":"2026.01.15","price":"0.41","value":null},{"date":"2026.01.14","price":"0.56","value":null},{"date":"2026.01.13","price":"-1.37","value":null},{"date":"2026.01.12","price":"1.75","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 华兰股份 | 37.81% | 6.58% | 6.2分 |
| 2 | 振德医疗 | 30.99% | 28.71% | 5.6分 |
| 3 | 宝莱特 | 26.40% | 13.22% | 5.0分 |
| 4 | 赛科希德 | 22.17% | 16.26% | 5.5分 |
| 5 | 凯普生物 | 20.36% | 0.27% | 3.8分 |
| 6 | 西山科技 | 19.01% | 2.66% | 5.1分 |
| 8 | 维力医疗 | 11.46% | 5.05% | 6.2分 |
| 10 | 奥精医疗 | 10.72% | 13.24% | 5.9分 |
| 12 | ST凯利 | 10.30% | 4.02% | 5.4分 |
| 14 | 采纳股份 | 9.14% | 11.94% | 5.2分 |
| 16 | 东星医疗 | 8.46% | 0.79% | 5.3分 |
| 18 | 黄山胶囊 | 7.51% | 2.42% | 6.2分 |
| 20 | 山外山 | 6.47% | -0.69% | 5.4分 |
| 22 | 英科医疗 | 5.61% | 2.60% | 4.0分 |
| 24 | 奥泰生物 | 4.74% | -0.17% | 4.3分 |
| 26 | 明德生物 | 2.71% | 1.20% | 3.8分 |
| 28 | 正川股份 | 2.62% | 2.52% | 4.9分 |
| 30 | 基蛋生物 | 2.30% | 4.47% | 4.8分 |
| 32 | 中红医疗 | 1.73% | 8.15% | 5.4分 |
| 34 | 达安基因 | 1.56% | 2.68% | 4.9分 |
| 36 | 海泰新光 | 0.95% | 2.98% | 5.4分 |
| 38 | 之江生物 | 0.90% | -1.84% | 3.4分 |
| 40 | 美康生物 | 0.68% | 3.19% | 4.0分 |
| 42 | 昊海生科 | 0.23% | 1.86% | 5.0分 |
| 44 | 健尔康 | 0.00% | 0.85% | 4.6分 |
| 46 | 三鑫医疗 | -0.21% | 3.61% | 5.0分 |
| 48 | 理邦仪器 | -0.34% | 3.36% | 5.7分 |
| 50 | 五洲医疗 | -0.45% | 3.65% | 5.2分 |
| 52 | 力诺药包 | -1.29% | 0.33% | 4.7分 |
| 54 | 康拓医疗 | -1.72% | 3.04% | 5.5分 |
| 56 | 威高血净 | -2.13% | 0.82% | 5.4分 |
| 58 | 迈普医学 | -2.26% | 0.27% | 6.3分 |
| 60 | 英诺特 | -2.33% | -0.85% | 3.9分 |
| 62 | 艾德生物 | -2.66% | -0.70% | 4.9分 |
| 64 | 欧普康视 | -2.81% | 0.31% | 4.6分 |
| 66 | 楚天科技 | -2.92% | -0.36% | 4.4分 |
| 68 | 乐心医疗 | -3.06% | 3.48% | 5.4分 |
| 70 | 东方生物 | -3.31% | 2.60% | 4.3分 |
| 72 | 康泰医学 | -3.58% | 2.36% | 4.4分 |
| 74 | 东方海洋 | -3.70% | 4.00% | 5.9分 |
| 76 | 康众医疗 | -4.02% | -10.97% | 3.3分 |
| 78 | 康为世纪 | -4.18% | -2.97% | 3.6分 |
| 80 | 济高发展 | -4.48% | 1.49% | 4.2分 |
| 82 | 赛诺医疗 | -4.75% | -4.75% | 4.3分 |
| 84 | 奥美医疗 | -5.54% | 5.93% | 4.7分 |
| 86 | 爱博医疗 | -6.24% | 0.80% | 4.3分 |
| 88 | 超研股份 | -6.69% | 1.54% | 5.6分 |
| 90 | 微电生理 | -6.95% | 1.88% | 4.1分 |
| 92 | 中源协和 | -7.05% | 2.66% | 4.6分 |
| 94 | 开立医疗 | -7.34% | -1.09% | 4.2分 |
| 96 | 惠泰医疗 | -7.84% | 6.26% | 5.3分 |
| 98 | 海尔生物 | -8.50% | 0.98% | 4.2分 |
| 100 | 东富龙 | -8.61% | -0.43% | 4.5分 |
| 102 | 万东医疗 | -8.68% | 0.75% | 4.5分 |
| 104 | 佰仁医疗 | -9.37% | -1.28% | 3.6分 |
| 106 | 浩欧博 | -9.44% | -0.68% | 4.6分 |
| 108 | 冠昊生物 | -9.61% | 0.83% | 5.0分 |
| 110 | - | -10.17% | 0.41% | 分 |
| 112 | 澳华内镜 | -10.38% | -1.72% | 3.5分 |
| 114 | 乐普医疗 | -11.11% | 1.01% | 5.5分 |
| 116 | 瑞迈特 | -12.24% | 2.52% | 5.0分 |
| 118 | 九强生物 | -12.54% | 1.22% | 3.7分 |
| 120 | 春立医疗 | -12.87% | -1.54% | 4.5分 |
| 122 | 美好医疗 | -13.50% | -0.66% | 5.2分 |
| 124 | - | -14.16% | -0.09% | 分 |
| 126 | 麦澜德 | -14.56% | 1.36% | 4.7分 |
| 128 | 伟思医疗 | -16.78% | 0.82% | 4.7分 |
| 130 | 福瑞医科 | -17.63% | 2.14% | 5.4分 |
| 132 | 博拓生物 | -18.96% | 4.09% | 3.9分 |
| 134 | 热景生物 | -23.11% | 3.15% | 3.6分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 22/247 ， 17/247。
[{"date":"2025-09-30","value":"9.17","vol":"2.98"},{"date":"2025-06-30","value":"5.30","vol":"2.34"},{"date":"2025-03-31","value":"3.36","vol":"1.16"},{"date":"2024-12-31","value":"12.65","vol":"0.56"},{"date":"2024-09-30","value":"11.60","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
9.17 | 5.30 | 3.36 | 12.65 | 11.60 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"73.17","vol":"51.73"},{"date":"2025-06-30","value":"73.16","vol":"52.04"},{"date":"2025-03-31","value":"75.86","vol":"51.41"},{"date":"2024-12-31","value":"73.46","vol":"52.51"},{"date":"2024-09-30","value":"74.81","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
73.17 | 73.16 | 75.86 | 73.46 | 74.81 |
| 行业(%) | 51.73 | 52.04 | 51.41 | 52.51 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 67/247 ， 72/247。
[{"date":"2025-09-30","value":"0.13","vol":"0.24"},{"date":"2025-06-30","value":"-1.42","vol":"-1.07"},{"date":"2025-03-31","value":"2.95","vol":"-0.10"},{"date":"2024-12-31","value":"4.40","vol":"1.15"},{"date":"2024-09-30","value":"8.44","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.13 | -1.42 | 2.95 | 4.40 | 8.44 |
| 行业(%) | 0.24 | -1.07 | -0.10 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-15.41","vol":"-15.37"},{"date":"2025-06-30","value":"-22.93","vol":"-18.14"},{"date":"2025-03-31","value":"-16.93","vol":"-2.59"},{"date":"2024-12-31","value":"-14.16","vol":"-23.09"},{"date":"2024-09-30","value":"-2.87","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-15.41 | -22.93 | -16.93 | -14.16 | -2.87 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 66/247 ， 28/247。
[{"date":"2025-09-30","value":"0.23","vol":"0.25"},{"date":"2025-06-30","value":"0.14","vol":"0.17"},{"date":"2025-03-31","value":"0.08","vol":"0.08"},{"date":"2024-12-31","value":"0.31","vol":"0.36"},{"date":"2024-09-30","value":"0.25","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.23 | 0.14 | 0.08 | 0.31 | 0.25 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.26","vol":"1.66"},{"date":"2025-06-30","value":"1.40","vol":"1.12"},{"date":"2025-03-31","value":"0.72","vol":"0.55"},{"date":"2024-12-31","value":"3.03","vol":"2.32"},{"date":"2024-09-30","value":"2.23","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.26 | 1.40 | 0.72 | 3.03 | 2.23 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"46.13","vol":"14.75"},{"date":"2025-06-30","value":"29.90","vol":"15.16"},{"date":"2025-03-31","value":"41.42","vol":"4.21"},{"date":"2024-12-31","value":"24.74","vol":"29.34"},{"date":"2024-09-30","value":"47.94","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 46.13 | 29.90 | 41.42 | 24.74 | 47.94 |
| 行业 | 14.75 | 15.16 | 4.21 | 29.34 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.65","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.30","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.65 | - | 1.30 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 80/247 ， 66/247。
[{"date":"2025-09-30","value":"5.10","vol":"5.66"},{"date":"2025-06-30","value":"6.44","vol":"5.47"},{"date":"2025-03-31","value":"5.81","vol":"5.84"},{"date":"2024-12-31","value":"5.87","vol":"5.30"},{"date":"2024-09-30","value":"5.92","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
5.10 | 6.44 | 5.81 | 5.87 | 5.92 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.18","vol":"4.51"},{"date":"2025-06-30","value":"4.12","vol":"4.35"},{"date":"2025-03-31","value":"3.61","vol":"4.73"},{"date":"2024-12-31","value":"3.63","vol":"4.27"},{"date":"2024-09-30","value":"3.81","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.18 | 4.12 | 3.61 | 3.63 | 3.81 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 79/247 ， 75/247。
[{"date":"2025-09-30","value":"15.48","vol":"22.07"},{"date":"2025-06-30","value":"13.47","vol":"22.01"},{"date":"2025-03-31","value":"14.85","vol":"21.19"},{"date":"2024-12-31","value":"14.71","vol":"21.94"},{"date":"2024-09-30","value":"14.84","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
15.48 | 13.47 | 14.85 | 14.71 | 14.84 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.20","vol":"0.71"},{"date":"2025-06-30","value":"0.17","vol":"0.58"},{"date":"2025-03-31","value":"0.19","vol":"0.56"},{"date":"2024-12-31","value":"0.19","vol":"0.55"},{"date":"2024-09-30","value":"0.19","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.20 | 0.17 | 0.19 | 0.19 | 0.19 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"5.55","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"6.24","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.67","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.72","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.92","blueLineValue":"0.66","type":"YC"}]